UNSPSC 85816325: Introduction of monoclonal antibody into peripheral vein, percutaneous approach

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 85816325

Definition

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0330M

About UNSPSC 85816325

UNSPSC 85816325 Introduction of monoclonal antibody into peripheral vein, percutaneous approach is a Commodity code with minimal recent state and local procurement activity aligned to its clinical scope. The recent opportunities tagged under this code span telehealth urgent care, occupational health services, employee wellness platforms, opioid use disorder treatment, cancer screening, youth crisis stabilization, behavioral health day treatment, and inmate healthcare—work substantially unrelated to the injection of monoclonal antibodies into peripheral veins. This code mismatch signals that state and local procurement offices are either using this Commodity code for broad categorization of clinical and health services contracting outside its specific procedural scope, or that recent opportunities have been mislabeled. The issuing bodies in the dataset include health plans (Inland Empire Health Plan in California), county departments (DeKalb County Georgia, Ventura County California, Jackson County Missouri), state authorities (Nevada Health Authority, Colorado Department of Human Services, Texas Health and Human Services Commission), municipalities (City of Atlanta, City of Phoenix, City of Ocala Florida), school districts (Parkway School District), and transit or behavioral health authorities across multiple states.

Geographic activity spans California (San Mateo County, Ventura County, Inland Empire), Georgia (DeKalb County, Forsyth County, Cobb County), Nevada, Colorado, Texas, Florida (Seminole County, Sarasota County, Marion County), Kansas (Sedgwick County), Oregon, New Jersey, Arizona (Phoenix), Illinois, New York (Rockland County), and the District of Columbia. Representative recent opportunities include Inland Empire Health Plan's RFI for 24/7/365 virtual urgent care services with a response deadline of October 31, 2026; Nevada Health Authority's RFP 41NHA-S4038 for Program of All Inclusive Care for the Elderly (PACE) operations across multiple Nevada service areas due December 10, 2026; San Mateo County's RFP for Cancer Registry Services due November 6, 2026; and the City of Phoenix's RFP for cancer screening services for city employees due February 2, 2026 with a maximum annual value of $3,500,000. The code itself does not appear to drive procurement activity in state and local markets at present; business development activity under this Commodity should verify actual coding before investing pursuit resources.

Quick answers

What is UNSPSC 85816325?

UNSPSC 85816325 is Introduction of monoclonal antibody into peripheral vein, percutaneous approach, a commodity in UNSPSC 85000000, Healthcare Services.

Which NIGP codes match UNSPSC 85816325?

UNSPSC 85816325 maps to 1 NIGP code, 94848 Health Care Services (Not Otherwise Classified).

On GovTribe

See everything under UNSPSC 85816325

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code